HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of eosinophilia on the heterogeneity of the anticoagulant response to heparin in haemodialysis patients.

Abstract
The anticoagulant response to heparin was determined, during haemodialysis, in a group of seven patients with eosinophilia and in a control group. The heparin half-life was similar in the two groups, but the heparin effect index was lower in patients with eosinophilia. The dose-response curve showed a reduced sensitivity to heparin in patients with eosinophilia. In patients with eosinophilia a significant reduction in eosinophil count was observed during cuprophan dialysis, but not during polyacrylonitrile dialysis. The hyposensitivity to heparin might be related to eosinophil degranulation, during cuprophan dialysis, with release of a major basic protein that neutralises heparin.
AuthorsA Santoro, P Zucchelli, E Trombetti, E Degli Esposti, A Sturani, A Zuccalà, C Chiarini, M Casadei-Maldini, A Mazzuca
JournalProceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress (Proc Eur Dial Transplant Assoc Eur Ren Assoc) Vol. 21 Pg. 143-9 ( 1985) England
PMID3991493 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Heparin
Topics
  • Adult
  • Blood Coagulation (drug effects)
  • Drug Resistance
  • Eosinophilia (blood)
  • Female
  • Heparin (blood, pharmacology)
  • Humans
  • Male
  • Middle Aged
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: